Glasshouse Advisory’s R&D Tax and EMDG practices have transferred to leading independent assurance, tax and advisory firm, Grant Thornton.
We help those who are considering Australia for clinical trials navigate Australia’s tax system to ensure you maximise your benefit and minimise your risk.
If you are thinking of conducting clinical trials in Australia you may already know of the high-quality research facilities available, alongside the pragmatic and efficient regulatory framework. Australia’s health care system is not dissimilar to that of the rest of the Western World, so it makes like-for-like comparisons straightforward.
Crucially, clinical trials in Australia are extremely cost effective. Firstly, the Australian dollar often makes the cost of a trial more affordable than if it had been undertaken in the home country of the pharmaceutical company. The R&D tax incentive program provides further relief by offering an up to 43.5% cash refund for the cost of the clinical trial.
For example, if you have established your Australian presence and your Australian clinical trial costs AUD$1,000,000 in 2020:
The example above assumes that the Australian entity is eligible for the 43.5% cash refund – this is available where global group turnover is AUD$20,000,000 or less.
There are certain criteria to ensure your clinical trial is eligible for the Australian R&D tax incentive. Companies looking to create a presence here in Australia will satisfy the first step to eligibility. This is necessary as the program runs through the Australian taxation system. Other issues relevant to eligibility and the refund or tax offset due include:
Glasshouse Advisory can assist you in working your way through these eligibility matters.
We have a suggested legal, entity and transactional structure that will minimise your upfront outlay in Australia, minimise tax risk and maximise your R&D refund. We will tailor the approach to fit your needs. Please contact us if you would further details.
- R&D services agreement
- Any loan agreement
Can be prepared as legal agreements by our lawyers if required
Glasshouse Advisory offers the following services necessary to claim the R&D tax incentive:
We can also provide recommendations for the following services:
We work with these services providers consistently and know they offer quality services and value for money.
The above represent the full range of services required to ensure your clinical trail reaps the benefit of the Australian R&D tax incentive program.
We have a team of R&D and tax experts to ensure your business benefits from the R&D tax incentive program in Australia. The team has deep experience in undertaking these projects with a history of successes.
Our R&D team has a 100% audit record. Glasshouse Advisory’s detailed lodgement methodology and substantiation process has led to an excellent reputation with the ATO and AusIndustry. We will maximise your claim without exposure to unwanted risk.
We are uniquely placed in the market to assist you in setting up your Australian business, minimising your Australian tax risk and undertaking your annual R&D returns.
Please do contact us so we can take you through the process and tailor a plan for your business.